Aleksandra Wlodek
Research Subjects
Aleksandra Wlodek has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Adam Hold
Isomerase Therapeutics Ltd., Chesterford Research Park, Cambridge, UK
1 shared publicationAlexander Alanine
Roche Innovation Center Basel, Pharmaceutical Research and Early Development (PRED), Basel, Switzerland
1 shared publicationAnna E. Stanley-Smith
Isomerase Therapeutics Ltd., Chesterford Research Park, Cambridge, UK
1 shared publication- Barrie Wilkinson
Department of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, NR4 7UH, UK
1 shared publication Christine J. Martin
Biotica Technology Ltd., Chesterford Research Park, Cambridge, UK
1 shared publicationDaniel Heine
Department of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, UK
1 shared publication
Latest Publications
- Open Access
- 31 October 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-10
Diversity oriented biosynthesis via accelerated evolution of modular gene clusters
Erythromycin, avermectin and rapamycin are clinically useful polyketide natural products produced on modular polyketide synthase multienzymes by an assembly-line process in which each module of enzymes in turn specifies attachment of a particular chemical unit. Although polyketide synthase encoding genes have been successfully engineered to produce novel analogues, the process can be relatively slow, inefficient, and frequently low-yielding. We now describe a method for rapidly recombining polyketide synthase gene clusters to replace, add or remove modules that, with high frequency, generates diverse and highly productive assembly lines. The method is exemplified in the rapamycin biosynthetic gene cluster where, in a single experiment, multiple strains were isolated producing new members of a rapamycin-related family of polyketides. The process mimics, but significantly accelerates, a plausible mechanism of natural evolution for modular polyketide synthases. Detailed sequence analysis of the recombinant genes provides unique insight into the design principles for constructing useful synthetic assembly-line multienzymes.
- 31 October 2017
- Published by Springer Nature in Nature Communications
- Vol. 8 (1) , 1-10
Open AccessDiversity oriented biosynthesis via accelerated evolution of modular gene clusters
Erythromycin, avermectin and rapamycin are clinically useful polyketide natural products produced on modular polyketide synthase multienzymes by an assembly-line process in which each module of enzymes in turn specifies attachment of a particular chemical unit. Although polyketide synthase encoding genes have been successfully engineered to produce novel analogues, the process can be relatively slow, inefficient, and frequently low-yielding. We now describe a method for rapidly recombining polyketide synthase gene clusters to replace, add or remove modules that, with high frequency, generates diverse and highly productive assembly lines. The method is exemplified in the rapamycin biosynthetic gene cluster where, in a single experiment, multiple strains were isolated producing new members of a rapamycin-related family of polyketides. The process mimics, but significantly accelerates, a plausible mechanism of natural evolution for modular polyketide synthases. Detailed sequence analysis of the recombinant genes provides unique insight into the design principles for constructing useful synthetic assembly-line multienzymes.